Tailored 70S30C Bioactive Glass Induces Severe Inflammation As Pulpotomy Agent in Primary Teeth: an Interim Analysis of a Randomised Controlled Trial

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2021 Jan 7

PMID 33409691

Citations 4

Authors

Yasmine Elhamouly

Rania M El Backly

Dalia M Talaat

Samia S Omar

Maha El Tantawi

Karin M L Dowidar

Affiliations

Soon will be listed here.

Abstract

Objectives: This study compared clinical, histologic, and inflammatory outcomes of Biodentine and Bioactive glass (70S30C-BAG) as pulpotomy agents in primary teeth.

Methods: A randomised, clinical trial was performed recruiting 70 children, 5-9 years old, having ≥ 1 tooth indicated for vital pulpotomy. Participants were randomised to Biodentine or 70S30C-BAG groups. Clinical evaluation was scheduled at 1, 3, 6, 9, and 12 months. Additional 16 teeth were extracted after 6 weeks to assess histologic and inflammatory response (IL-8/IL-10 ratio) using ELISA. Fisher exact, Mann Whitney U test, and t test were used to compare clinical, histologic outcomes and IL-8/IL-10 ratio.

Results: After 3 months, 10 teeth treated with Biodentine were clinically successful, while 9 teeth treated with 70S30C-BAG failed (P < 0.001) necessitating trial termination. Causes of failure were analysed by assessing the pH and ionic release of 70S30C-BAG. Biodentine-treated teeth showed minor inflammation, normal pulp, and hard tissue formation.70S30C-BAG-treated teeth showed severe inflammation, abscesses, root resorption without hard tissue formation. There was a significantly greater percent reduction of IL-8/IL-10 ratio in Biodentine than 70S30C-BAG (mean ± SD = 66.39 ± 18.56 and 40.66 ± 0.86, P = 0.02).

Conclusions: Biodentine showed favourable clinical, histologic, and anti-inflammatory outcomes, promoting pulp healing and regeneration. 70S30C-BAG resulted in pulp necrosis-through persistent inflammation-causing clinical failure.

Clinical Relevance: Biodentine is a promising pulpotomy agent in primary teeth; it promoted healing and regeneration of the dentine-pulp complex. In its current form, 70S30C-BAG is not a suitable pulpotomy agent; it induced persistent inflammation, negating the pulp ability to heal and regenerate. TRN: NCT03786302, 12/19/2018.

Citing Articles

Outcome assessment methods of bioactive and biodegradable materials as pulpotomy agents in primary and permanent teeth: a scoping review.

Elhamouly Y, Adham M, Dowidar K, El Backly R BMC Oral Health. 2024; 24(1):496.

PMID: 38678210 PMC: 11055312. DOI: 10.1186/s12903-024-04221-w.

Advances and challenges in regenerative dentistry: A systematic review of calcium phosphate and silicate-based materials on human dental pulp stem cells.

Christie B, Musri N, Djustiana N, Takarini V, Tuygunov N, Zakaria M Mater Today Bio. 2023; 23:100815.

PMID: 37779917 PMC: 10539671. DOI: 10.1016/j.mtbio.2023.100815.

Sol-gel synthesis of lithium doped mesoporous bioactive glass nanoparticles and tricalcium silicate for restorative dentistry: Comparative investigation of physico-chemical structure, antibacterial susceptibility and biocompatibility.

Simila H, Boccaccini A Front Bioeng Biotechnol. 2023; 11:1065597.

PMID: 37077228 PMC: 10106781. DOI: 10.3389/fbioe.2023.1065597.

Present status and future directions: Hydraulic materials for endodontic use.

Camilleri J, Atmeh A, Li X, Meschi N Int Endod J. 2022; 55 Suppl 3:710-777.

PMID: 35167119 PMC: 9314068. DOI: 10.1111/iej.13709.

References

Laurent P, Camps J, About I . Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization. Int Endod J. 2011; 45(5):439-48. DOI: 10.1111/j.1365-2591.2011.01995.x. View

Cuadros-Fernandez C, Lorente Rodriguez A, Saez-Martinez S, Garcia-Binimelis J, About I, Mercade M . Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clin Oral Investig. 2015; 20(7):1639-45. DOI: 10.1007/s00784-015-1656-4. View

Rajasekharan S, Martens L, Vandenbulcke J, Jacquet W, Bottenberg P, Cauwels R . Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J. 2016; 50(3):215-228. DOI: 10.1111/iej.12619. View

Grewal N, Salhan R, Kaur N, Patel H . Comparative evaluation of calcium silicate-based dentin substitute (Biodentine) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemp Clin Dent. 2016; 7(4):457-463. PMC: 5141658. DOI: 10.4103/0976-237X.194116. View

Galler K, DSouza R, Hartgerink J, Schmalz G . Scaffolds for dental pulp tissue engineering. Adv Dent Res. 2011; 23(3):333-9. DOI: 10.1177/0022034511405326. View

Jones J, Ehrenfried L, Hench L . Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials. 2005; 27(7):964-73. DOI: 10.1016/j.biomaterials.2005.07.017. View

Haghgoo R, Ahmadvand M . Evaluation of pulpal response of deciduous teeth after direct pulp capping with bioactive glass and mineral trioxide aggregate. Contemp Clin Dent. 2016; 7(3):332-5. PMC: 5004546. DOI: 10.4103/0976-237X.188552. View

Long Y, Liu S, Zhu L, Liang Q, Chen X, Dong Y . Evaluation of Pulp Response to Novel Bioactive Glass Pulp Capping Materials. J Endod. 2017; 43(10):1647-1650. DOI: 10.1016/j.joen.2017.03.011. View

Midha S, Kim T, van den Bergh W, Lee P, Jones J, Mitchell C . Preconditioned 70S30C bioactive glass foams promote osteogenesis in vivo. Acta Biomater. 2013; 9(11):9169-82. DOI: 10.1016/j.actbio.2013.07.014. View

10.

Wang S, Gao X, Gong W, Zhang Z, Chen X, Dong Y . Odontogenic differentiation and dentin formation of dental pulp cells under nanobioactive glass induction. Acta Biomater. 2014; 10(6):2792-803. DOI: 10.1016/j.actbio.2014.02.013. View

11.

Lopez T, Diniz I, Ferreira L, Marchi J, Borges R, de Cara S . Bioactive glass plus laser phototherapy as promise candidates for dentine hypersensitivity treatment. J Biomed Mater Res B Appl Biomater. 2015; 105(1):107-116. DOI: 10.1002/jbm.b.33532. View

12.

Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M . Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011; 7(6):2644-50. DOI: 10.1016/j.actbio.2011.03.009. View

13.

ElSalhy M, Azizieh F, Raghupathy R . Cytokines as diagnostic markers of pulpal inflammation. Int Endod J. 2012; 46(6):573-80. DOI: 10.1111/iej.12030. View

14.

Magloire H, Romeas A, Melin M, Couble M, Bleicher F, Farges J . Molecular regulation of odontoblast activity under dentin injury. Adv Dent Res. 2003; 15:46-50. DOI: 10.1177/08959374010150011201. View

15.

Salako N, Joseph B, Ritwik P, Salonen J, John P, Junaid T . Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar. Dent Traumatol. 2004; 19(6):314-20. DOI: 10.1046/j.1600-9657.2003.00204.x. View

16.

Wang S, Falk M, Rashad A, Saad M, Marques A, Almeida R . Evaluation of 3D nano-macro porous bioactive glass scaffold for hard tissue engineering. J Mater Sci Mater Med. 2011; 22(5):1195-203. DOI: 10.1007/s10856-011-4297-4. View

17.

Althunian T, de Boer A, Groenwold R, Klungel O . Defining the noninferiority margin and analysing noninferiority: An overview. Br J Clin Pharmacol. 2017; 83(8):1636-1642. PMC: 5510081. DOI: 10.1111/bcp.13280. View

18.

Kusum B, Rakesh K, Richa K . Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth. Restor Dent Endod. 2015; 40(4):276-85. PMC: 4650523. DOI: 10.5395/rde.2015.40.4.276. View

19.

Agamy H, Bakry N, Mounir M, Avery D . Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent. 2004; 26(4):302-9. View

20.

Saghaei M . Random allocation software for parallel group randomized trials. BMC Med Res Methodol. 2004; 4:26. PMC: 533876. DOI: 10.1186/1471-2288-4-26. View